Form 4: Koru Medical Systems Director Acquires Shares in Recent Transaction
SEC Form 4 Filing
Director Shahriar Matin acquired 5,545 shares of Koru Medical Systems, Inc. at a price of $2.71 on July 11, 2024, increasing his total holdings to 68,154 shares.
Summary
- On July 11, 2024, Shahriar Matin, a director of Koru Medical Systems, Inc., acquired 5,545 shares of common stock.
- The shares were purchased at a price of $2.71 per share.
- Following the transaction, Matin's total beneficial ownership in Koru Medical Systems, Inc. amounts to 68,154 shares.
- A Power of Attorney was filed, authorizing Linda Tharby and Thomas Adams to act on Matin's behalf for SEC filings related to Koru Medical Systems, Inc.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a director's stock purchase. It doesn't inherently convey strong positive or negative sentiment, but insider buying is generally viewed neutrally to slightly positively.
Positives
- A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.
Industry Context
This filing is a routine disclosure of insider trading activity, which is common in publicly traded companies. It provides transparency into the actions of company insiders.
Stakeholder Impact
- Shareholders may view the director's stock purchase as a positive sign.
Key Dates
| Date | Description |
|---|---|
| June 19 2024 | Date of execution of Power of Attorney. |
| July 11 2024 | Date of stock acquisition by Shahriar Matin. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.